BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 23616309)

  • 1. Gut microbiota and obesity: lessons from the microbiome.
    Cani PD
    Brief Funct Genomics; 2013 Jul; 12(4):381-7. PubMed ID: 23616309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota composition and its effects on obesity and insulin resistance.
    Caricilli AM; Saad MJ
    Curr Opin Clin Nutr Metab Care; 2014 Jul; 17(4):312-8. PubMed ID: 24848531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters.
    Ellekilde M; Krych L; Hansen CH; Hufeldt MR; Dahl K; Hansen LH; Sørensen SJ; Vogensen FK; Nielsen DS; Hansen AK
    Res Vet Sci; 2014 Apr; 96(2):241-50. PubMed ID: 24556473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenomics: key to human gut microbiota.
    Maccaferri S; Biagi E; Brigidi P
    Dig Dis; 2011; 29(6):525-30. PubMed ID: 22179207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overweight and the feline gut microbiome - a pilot study.
    Kieler IN; Mølbak L; Hansen LL; Hermann-Bank ML; Bjornvad CR
    J Anim Physiol Anim Nutr (Berl); 2016 Jun; 100(3):478-84. PubMed ID: 26452635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the human gut microbiota in metabolic diseases.
    Karlsson F; Tremaroli V; Nielsen J; Bäckhed F
    Diabetes; 2013 Oct; 62(10):3341-9. PubMed ID: 24065795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity.
    Remely M; Aumueller E; Jahn D; Hippe B; Brath H; Haslberger AG
    Benef Microbes; 2014 Mar; 5(1):33-43. PubMed ID: 24533976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomic surveys of gut microbiota.
    Mandal RS; Saha S; Das S
    Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):148-58. PubMed ID: 26184859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host responses to the human microbiome.
    Bäckhed F
    Nutr Rev; 2012 Aug; 70 Suppl 1():S14-7. PubMed ID: 22861802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics, gut microbiota and health.
    Butel MJ
    Med Mal Infect; 2014 Jan; 44(1):1-8. PubMed ID: 24290962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human gut microbiome and its dysfunctions.
    Mondot S; de Wouters T; Doré J; Lepage P
    Dig Dis; 2013; 31(3-4):278-85. PubMed ID: 24246975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.
    Caesar R; Fåk F; Bäckhed F
    J Intern Med; 2010 Oct; 268(4):320-8. PubMed ID: 21050286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.